addenda and errata\(\def\hfill{\hskip 5em}\def\hfil{\hskip 3em}\def\eqno#1{\hfil {#1}}\)

Journal logoCRYSTALLOGRAPHIC
COMMUNICATIONS
ISSN: 2056-9890

2-(Imidazol-1-yl)-1-(2-naphthyl)­ethano­ne O-propyl­oxime hydro­chloride. Erratum

CROSSMARK_Color_square_no_text.svg

aDepartment of Engineering Physics, Hacettepe University, Beytepe 06532, Ankara, Turkey, bDepartment of Pharmaceutical Chemistry, Hacettepe University, Sıhhiye 06100, Ankara, Turkey, and cDepartment of Pharmaceutical Chemistry, Ankara University, Sıhhiye 06100, Ankara, Turkey
*Correspondence e-mail: sozbey@hacettepe.edu.tr

(Received 1 June 2003; accepted 2 June 2003; online 10 July 2003)

In the paper by Özbey et al. [Acta Cryst. (2002), E58, o1269–o1271], the Scheme and systematic name are incorrect. The correct Scheme is shown below and the correct systematic name is 1-[2-(2-naphthyl)-2-(propoxy­imino)­ethyl]­imidazol-3-ium chlor­ide.[link]

[Scheme 1]
Follow Acta Cryst. E
Sign up for e-alerts
Follow Acta Cryst. on Twitter
Follow us on facebook
Sign up for RSS feeds